Ali Asif
SEC CIK 1921163 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | CFO | 59.0K | — | $10.29M | 24 | 2022-04-18 | 2026-04-20 |
Most active insiders at PTGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DINESH V PH D | Pres, CEO, Dir | — | $60.58M |
| 2 | Ali Asif | CFO | — | $7.32M |
| 3 | Giraudo Bryan | Dir | — | $5.92M |
| 4 | Waddill William D. | Dir | — | $5.58M |
| 5 | MOLINA ARTURO MD | Chief Medical Off | — | $4.49M |
| 6 | SELICK HAROLD E | Dir | — | $2.52M |
| 7 | Williams Lewis T | Dir | — | $1.48M |
| 8 | O'Dowd Sarah A | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 16:58 | 2026-04-20 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale | $105.47 | -1,750 | 59.0K | -3% | -$184.6K | |
| D | 2026-03-27 | 2026-03-26 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale+OE | $104.24 | -24.8K | 60.8K | -29% | -$2.58M |
| DM | 2026-03-27 | 2026-03-26 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | M - OptEx | $17.70 | +24.8K | 80.3K | +45% | +$438.3K |
| DM | 2026-01-27 | 2026-01-27 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | M - OptEx | $16.18 | +28.0K | 94.5K | +42% | +$453.1K |
| DM | 2026-01-27 | 2026-01-27 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale+OE | $83.13 | -46.2K | 60.3K | -43% | -$3.84M |
| 2026-01-21 | 2026-01-20 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale | $82.48 | -8,588 | 78.1K | -10% | -$708.3K | |
| D | 2026-01-06 | 2026-01-02 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | A - Grant | $0.00 | +25.6K | 86.7K | +42% | $0 |
| 2025-04-23 | 2025-04-22 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale | $46.00 | -1,756 | 61.1K | -3% | -$80.8K | |
| DM | 2025-03-14 | 2025-03-12 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | M - OptEx | $14.90 | +24.9K | 87.7K | +40% | +$371.2K |
| D | 2025-03-14 | 2025-03-12 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale+OE | $58.73 | -24.9K | 62.8K | -28% | -$1.46M |
| M | 2025-01-17 | 2025-01-16 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale | $0.00 | -3,918 | 65.4K | -6% | $0 |
| D | 2025-01-06 | 2025-01-02 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | A - Grant | $0.00 | +31.8K | 66.7K | +91% | $0 |
| DM | 2024-09-13 | 2024-09-11 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | M - OptEx | $15.68 | +12.0K | 41.0K | +41% | +$188.2K |
| DM | 2024-09-13 | 2024-09-11 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale+OE | $44.49 | -14.2K | 35.0K | -29% | -$631.9K |
| 2024-04-19 | 2024-04-18 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale | $25.11 | -1,234 | 37.2K | -3% | -$31.0K | |
| DM | 2024-03-01 | 2024-02-29+ | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale+OE | $31.60 | -24.2K | 42.7K | -36% | -$764.4K |
| D | 2024-03-01 | 2024-03-01 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | M - OptEx | $12.17 | +12.0K | 52.6K | +30% | +$146.0K |
| 2024-01-18 | 2024-01-16 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | F - Tax | $24.63 | -1,452 | 50.6K | -3% | -$35.8K | |
| D | 2024-01-04 | 2024-01-02 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | A - Grant | $0.00 | +21.0K | 52.0K | +68% | $0 |
| 2023-06-02 | 2023-05-31 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | A - Grant | $0.00 | +12.0K | 35.2K | +52% | $0 | |
| 2023-06-02 | 2023-05-31 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | F - Tax | $26.07 | -4,150 | 31.0K | -12% | -$108.2K | |
| 2023-04-19 | 2023-04-18 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | F - Tax | $23.21 | -1,189 | 23.2K | -5% | -$27.6K | |
| D | 2023-01-18 | 2023-01-16 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | A - Grant | $0.00 | +10.6K | 24.4K | +77% | $0 |
| D | 2022-04-19 | 2022-04-18 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | A - Grant | $0.00 | +13.8K | 13.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations